On March 22, 2021, Partner and Co-Chair of Biologics Practice and China Practice Philip Braginsky co-authored the article, " Building Effective Intellectual Property Strategies Into Pharma M&A," featured in Patentography. The article explores the impact of intellectual property on business development and M&A for pharmaceutical companies. The authors explain the importance of understanding a company’s intellectual property assets and those of any targets for successful M&A strategies. They identify tactical synergies, investments, and integration issues as key components for an effective deal.

Read more here.